Royal Caribbean trials ‘cruises to nowhere’ with ships sailing in circles from Singapore


patrik stollarz/Agence France-Presse/Getty Images

Royal Caribbean International and Genting Cruise Lines, two of the world’s largest cruise lines, will start sailing again out of Singapore, but instead of whisking passengers to faraway lands, guests will pay thousands of dollars to go around in circles.

Loading...

Load Error

Ships have now been given the green lights to sail from the city-state’s port, after permission was granted by authorities in Singapore.

Cruise holidays already restarted in some countries from August, but the development in Singapore will be seen as a big boost because its port is a major travel hub in Asia.

Read: Check in, but don’t fly? Airlines launch ‘flights to nowhere’

The development will be welcome news for Royal Caribbean (RCL) and Genting (SG:G13) who have been hit hard, along with other holiday operators, by the impact of the coronavirus pandemic on tourism.

Cruise ships had been a particular focal

Read More

India to cooperate with Bangladesh in conducting trials, production, distribution of Covid-19 vaccines

India has said it will cooperate with Bangladesh in vaccine development for Covid-19, which would include conducting trials, production of the vaccine and its distribution, as and when vaccines are ready for use.

External Affairs Minister S Jaishankar also expressed India’s interest in cooperating with Bangladesh in renewable energy including solar projects at the India-Bangladesh Joint Coordination Committee (JCC) meeting that he co-chaired with his Bangladeshi counterpart AK Abdul Momen on Tuesday. The meeting was held virtually.

On vaccine development, Jaishankar said Bangladesh will be accorded high priority in all efforts. “We are ready to start Phase-III clinical trials in Bangladesh soon after we launch these trials in India. Common trials would certainly help strengthen cooperation among our regulators and simplify processes for future distribution and joint production of vaccines,” he said.

Till the time full scale flight operations are resumed between India and Bangladesh, India expressed hope that the

Read More

Trials For Russian Coronavirus Vaccine May Begin in India in Upcoming Weeks



a man wearing a blue hat


© Ritu Singh | India.com News Desk



New Delhi: With Russia’s latest tie-up with Dr Reddy Laboratories Ltd, the final stage clinical trials of the world’s first potential coronavirus vaccine – Sputnik V – could begin in India in the next few weeks. The COVID antidote, that has been developed by Russian Direct Investment Fund, is set to enroll at least 1,000 to 1,200 participants for the late-stage trials at multiple government and private hospitals across the country, officials at the drugmaker firm said. “We want to get to the first step – which is the commencement of the clinical trials by getting the necessary approvals from the Indian regulators – within the next few weeks,” Deepak Sapra, CEO for API and pharmaceutical services at Dr Reddy’s told Reuters. Notably, once approved, Russia is expected to supply 100 million doses of the coronavirus vaccine to India. Deliveries could potentially
Read More